Financial Post

NovaSure® V5 Global Endometrial Ablation Device Approved for Use in Canada and Europe

MARLBOROUGH, Mass. — Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health, has announced approval of the NovaSure ® V5 global endometrial ablation (GEA) device in Canada and Europe. This ...
The Providence Journal

Hologic Launches Next-Generation NovaSure Global Endometrial Ablation System for the Treatment of Abnormal Uterine Bleeding (Menorrhagia)

BEDFORD, Mass., Nov. 19, 2014 /PRNewswire/ -- Hologic, Inc. , today announced the launch of the next-generation NovaSure 6mm global endometrial ablation (GEA) system. The NovaSure system is designed ...
Nasdaq

Hologic to Launch the NovaSure® V5 Global Endometrial Ablation Device at Upcoming American Association of Gynecologic Laparoscopists 50th Global Congress

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...